Céline Callens
Impact in
- Cancer Research top 2%
- Cancer Genomics and Diagnostics
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Oncology top 5%
Papers in
- Oncology 30
- PARP inhibition in cancer therapy 11
- HER2/EGFR in Cancer Research 5
-
- Advanced Breast Cancer Therapies 10
- Lung Cancer Treatments and Mutations 9
- Co-authors
- Ivan Bièche (37 shared papers)Sophie Vacher (18 shared papers)Rosette Lidereau (7 shared papers)François‐Clément Bidard (16 shared papers)Jean‐Yves Pierga (7 shared papers)Étienne Rouleau (10 shared papers)Walid Chemlali (6 shared papers)Didier Meseure (5 shared papers)
- Journals
- Journal of Clinical Oncology (10 papers)Cancer Research (6 papers)Annals of Oncology (5 papers)Lung Cancer (3 papers)Oncogene (2 papers)
- Partner nations
- FranceUnited StatesBelgium
In The Last Decade
Céline Callens
79 papers receiving 2.2k citations
Peers
Comparison fields: 5 of 99
- Cancer Research 670
- Oncology 579
- Gastroenterology 100
- Pathology and Forensic Medicine 314
- Hematology 193
Countries citing papers authored by Céline Callens
This map shows the geographic impact of Céline Callens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Céline Callens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Céline Callens more than expected).
Fields of papers citing papers by Céline Callens
This network shows the impact of papers produced by Céline Callens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Céline Callens. The network helps show where Céline Callens may publish in the future.
Co-authors
The 25 scholars most cited alongside Céline Callens, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 85 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 223 | |
| 2 | 2009 | 131 | |
| 3 | 2013 | 108 | |
| 4 | 2005 | 100 | |
| 5 | 2013 | 99 | |
| 6 | 2011 | 89 | |
| 7 | 2016 | 85 | |
| 8 | 2012 | 85 | |
| 9 | 2009 | 84 | |
| 10 | 2016 | 78 | |
| 11 | 2019 | 77 | |
| 12 | 2018 | 69 | |
| 13 | 2019 | 67 | |
| 14 | 2018 | 58 | |
| 15 | 2015 | 58 | |
| 16 | 2018 | 56 | |
| 17 | 2007 | 50 | |
| 18 | 2019 | 49 | |
| 19 | 2015 | 48 | |
| 20 | 2015 | 46 |
About Céline Callens
Céline Callens is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Genetics and Molecular Biology, having authored 85 papers that have together received 2.3k indexed citations. Recurring topics across this work include Cancer Genomics and Diagnostics (12 papers), PARP inhibition in cancer therapy (11 papers), Advanced Breast Cancer Therapies (10 papers), BRCA gene mutations in cancer (9 papers), Lung Cancer Treatments and Mutations (9 papers), Breast Cancer Treatment Studies (8 papers), Genetic factors in colorectal cancer (6 papers) and HER2/EGFR in Cancer Research (5 papers). The work is most often cited by research in Cancer Research (670 citations), Oncology (579 citations), Gastroenterology (100 citations), Pathology and Forensic Medicine (314 citations) and Hematology (193 citations). Céline Callens has collaborated with scholars based in France, United States and Belgium. Frequent co-authors include Ivan Bièche, Sophie Vacher, Rosette Lidereau, François‐Clément Bidard, Jean‐Yves Pierga, Étienne Rouleau, Walid Chemlali, Didier Meseure, Florence Lerebours and Samia Melaabi. Their work appears in journals such as Journal of Clinical Oncology, Cancer Research, Annals of Oncology, Lung Cancer and Oncogene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.